Press Releases

Results 361-370 of 482

Key Executive With Significant Hematology Drug Development Expertise Joins Actinium Pharmaceuticals as Head of Clinical Development

Aug 18, 2015

Actinium Successfully Labels Antibody with Actinium-225 For Next Entry into Pipeline

Aug 10, 2015

Actinium Issues Letter to Shareholders Outlining Measures to Move Iomab-B and Actimab-A Into Advanced Development

Aug 5, 2015

Actinium Advances Iomab-B Towards Phase 3 With Pre-IND Meeting Request

Jul 15, 2015

Actinium Files a Provisional Patent Application for Infusion Administration of Iomab-B

Jun 24, 2015

Actinium Announces Closing of $5 Million Registered Direct Offering of Common Stock

Jun 9, 2015

Actinium Announces $5 Million Registered Direct Offering of Common Stock

Jun 4, 2015

Actinium's Clinical Data Generate Significant Interest at 2015 ASCO Annual Meeting

Jun 4, 2015

Actinium's Actimab-A High Response Rates Presented at 2015 ASCO Annual Meeting

May 29, 2015

Actinium Clinical Update on Actimab-A Provided at Targeted Alpha Therapy Symposium

May 28, 2015